Hannah Kloha
Psychiatric/Mental Health · Midland, MINPI 1861085110
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 211 payments — averaging $26.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$886
- Otsuka America Pharmaceutical, Inc.$861
- Teva Pharmaceuticals USA, Inc.$710
- Lundbeck LLC$668
- Alkermes, Inc.$488
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$319
- plus $2K from 14 others
What the payments were for
- Food & beverage$5,51299%
- Education$521%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 25 | $886 |
| Otsuka America Pharmaceutical, Inc. | 42 | $861 |
| Teva Pharmaceuticals USA, Inc. | 26 | $710 |
| Lundbeck LLC | 28 | $668 |
| Alkermes, Inc. | 21 | $488 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $319 |
| Neurocrine Biosciences, Inc. | 10 | $313 |
| Supernus Pharmaceuticals, Inc. | 11 | $281 |
| Indivior Inc. | 10 | $218 |
| Axsome Therapeutics, Inc. | 4 | $201 |
| AbbVie | 9 | $144 |
| E.r. Squibb & Sons, L.L.C. | 4 | $139 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $133 |
| Vanda Pharmaceuticals Inc. | 1 | $81 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Biogen | 1 | $22 |
| Tempus AI, Inc | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Corium, LLC | 1 | $17 |
| Novo Nordisk | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$420
- UZEDY$225
- SPRAVATO$222
- CAPLYTA$153
- Austedo XR$125
How this compares
$5,564 in reported general payments places this provider in the 90th percentile of 638 psychiatric/mental health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 12 | $18,916 |
| Paliperidone ErPaliperidone | 18 | $7,782 |
| Divalproex Sodium ErDivalproex Sodium | 29 | $2,240 |
| Duloxetine Hcl | 30 | $2,215 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 51 | $1,679 |
| Trazodone Hcl | 103 | $1,526 |
| Bupropion XlBupropion Hcl | 46 | $1,507 |
| Aripiprazole | 33 | $1,437 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 17 | $1,268 |
| Escitalopram Oxalate | 62 | $1,228 |
| Buspirone Hcl | 55 | $1,191 |
| Risperidone | 31 | $1,001 |
| Oxcarbazepine | 22 | $967 |
| Fluvoxamine Maleate | 17 | $689 |
| Mirtazapine | 28 | $597 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $319 | $18,91612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 638 psychiatric/mental health providers in Michigan.
Other psychiatric/mental health in Midland
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Shiba NixonClarkston$60K
- Amy AmesClinton Township$43K
- Cody ShinavierClarkston$41K
- Oksana LidkeBattle Creek$30K
- Jennifer Wims-MaddenPontiac$28K
- Jessica ShantzWarren$21K
- Gladys KimeliSaginaw$17K
- Cynthia MaiSaginaw$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.